255 related articles for article (PubMed ID: 26260227)
21. Virotherapy--cancer targeted pharmacology.
Tedcastle A; Cawood R; Di Y; Fisher KD; Seymour LW
Drug Discov Today; 2012 Mar; 17(5-6):215-20. PubMed ID: 22198165
[TBL] [Abstract][Full Text] [Related]
22. Oncolytic viruses: perspectives on clinical development.
Burke J; Nieva J; Borad MJ; Breitbach CJ
Curr Opin Virol; 2015 Aug; 13():55-60. PubMed ID: 25989094
[TBL] [Abstract][Full Text] [Related]
23. Oncolytic viruses as platform for multimodal cancer therapeutics: a promising land.
Guo ZS; Bartlett DL
Cancer Gene Ther; 2014 Jul; 21(7):261-3. PubMed ID: 25034971
[No Abstract] [Full Text] [Related]
24. ReVOLT: radiation-enhanced viral oncolytic therapy.
Advani SJ; Mezhir JJ; Roizman B; Weichselbaum RR
Int J Radiat Oncol Biol Phys; 2006 Nov; 66(3):637-46. PubMed ID: 17011442
[TBL] [Abstract][Full Text] [Related]
25. In silico evolutionary dynamics of tumour virotherapy.
Reis CL; Pacheco JM; Ennis MK; Dingli D
Integr Biol (Camb); 2010 Jan; 2(1):41-5. PubMed ID: 20473411
[TBL] [Abstract][Full Text] [Related]
26. OvirusTdb: A database of oncolytic viruses for the advancement of therapeutics in cancer.
Lathwal A; Kumar R; Raghava GPS
Virology; 2020 Sep; 548():109-116. PubMed ID: 32838931
[TBL] [Abstract][Full Text] [Related]
27. Construction of recombinant Newcastle disease virus Italien strain for oncolytic virotherapy of tumors.
Wei D; Sun N; Nan G; Wang Y; Liu HQ; Peeters B; Chen ZN; Bian H
Hum Gene Ther; 2012 Jul; 23(7):700-10. PubMed ID: 22372930
[TBL] [Abstract][Full Text] [Related]
28. Newcastle disease virus as an oncolytic agent.
Ravindra PV; Tiwari AK; Sharma B; Chauhan RS
Indian J Med Res; 2009 Nov; 130(5):507-13. PubMed ID: 20090097
[TBL] [Abstract][Full Text] [Related]
29. Regulatory aspects of oncolytic virus products.
Yamaguchi T; Uchida E
Curr Cancer Drug Targets; 2007 Mar; 7(2):203-8. PubMed ID: 17346112
[TBL] [Abstract][Full Text] [Related]
30. Going viral: a review of replication-selective oncolytic adenoviruses.
Larson C; Oronsky B; Scicinski J; Fanger GR; Stirn M; Oronsky A; Reid TR
Oncotarget; 2015 Aug; 6(24):19976-89. PubMed ID: 26280277
[TBL] [Abstract][Full Text] [Related]
31. Oncolytic viruses: time to compare, contrast, and combine? 5th international meeting on replicating oncolytic virus therapeutics. Banff, Alberta, Canada, 18-22 March 2009.
Pandha H; Melcher A; Harrington K; Vile R
Mol Ther; 2009 Jun; 17(6):934-5. PubMed ID: 19483767
[No Abstract] [Full Text] [Related]
32. To Infection and Beyond: The Multi-Pronged Anti-Cancer Mechanisms of Oncolytic Viruses.
Cassady KA; Haworth KB; Jackson J; Markert JM; Cripe TP
Viruses; 2016 Feb; 8(2):. PubMed ID: 26861381
[TBL] [Abstract][Full Text] [Related]
33. A mathematical model of oncolytic virotherapy with time delay.
Wang ZZ; Guo ZM; Smith H
Math Biosci Eng; 2019 Mar; 16(4):1836-1860. PubMed ID: 31137188
[TBL] [Abstract][Full Text] [Related]
34. Designer nanocarriers for navigating the systemic delivery of oncolytic viruses.
Howard F; Muthana M
Nanomedicine (Lond); 2020 Jan; 15(1):93-110. PubMed ID: 31868115
[TBL] [Abstract][Full Text] [Related]
35. Generation of recombinant measles virus containing the wild-type P gene to improve its oncolytic efficiency.
Alizadeh R; Ghanei M; Arashkia A; Dorostkar R; Azadmanesh K
Microb Pathog; 2019 Oct; 135():103631. PubMed ID: 31381964
[No Abstract] [Full Text] [Related]
36. Questing for an optimal, universal viral agent for oncolytic virotherapy.
Paiva LR; Martins ML; Ferreira SC
Phys Rev E Stat Nonlin Soft Matter Phys; 2011 Oct; 84(4 Pt 1):041918. PubMed ID: 22181186
[TBL] [Abstract][Full Text] [Related]
37. [The use of oncolytic adenovirus for the treatment of cancer].
Cascalló M
Methods Find Exp Clin Pharmacol; 2010 Dec; 32 Suppl A():3-7. PubMed ID: 21381281
[TBL] [Abstract][Full Text] [Related]
38. Evolution of oncolytic viruses.
Sanjuán R; Grdzelishvili VZ
Curr Opin Virol; 2015 Aug; 13():1-5. PubMed ID: 25699475
[TBL] [Abstract][Full Text] [Related]
39. United virus: the oncolytic tag-team against cancer!
Le Boeuf F; Bell JC
Cytokine Growth Factor Rev; 2010; 21(2-3):205-11. PubMed ID: 20227326
[TBL] [Abstract][Full Text] [Related]
40. Oncolytic virotherapy for cancer treatment: challenges and solutions.
Davis JJ; Fang B
J Gene Med; 2005 Nov; 7(11):1380-9. PubMed ID: 16025557
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
